Home | Contact Us  

Objectives | Board of Directors
  The Alliance for Plasma Therapies is a national non-profit organization established to provide a unified, powerful voice of patient organizations, healthcare providers and industry leaders to educate about the diseases that rely on plasma derived therapies and advocate for fair access to plasma therapies for patients who benefit from their lifesaving effects.
 
 
The Alliance’s objectives are as follows:
to be a resource on plasma therapies and access to them for patients, providers, legislators, federal and state agencies, third-party payers, and others;
to establish a health insurance hotline to help individuals, patient groups, and medical societies handle denials of coverage for plasma therapies and to develop kits on insurance appeals;
to provide educational forums, workshops, and programs on plasma therapies;
to produce electronic and print educational materials and to provide educational resources on its website;
to educate Members of Congress and relevant agencies in the federal government (e.g., the Department of Health and Human Services) on the diseases that rely on plasma-derived therapies (e.g., intravenous immune globulin therapy or IVIG) and their lifesaving and life-enhancing abilities; and
to ensure fair and adequate reimbursement for all formulations of plasma-derived therapies in all sites of care.
 
 

Abbie Cornett, President and Chair
         Nebraska State Senator
         Diagnosis of primary immunodeficiency treated successfully
         with monthly IVIG

Roger Kobayashi, MD, Treasurer
         Clinical Professor, UCLA School of Medicine
         Senior Partner of Allergy, Asthma & Immunology Associates
         in Omaha, Nebraska

Bob Goldberg, Secretary
         Executive Director, The Myositis Association

Mary Alexander, RN, CRNI®, CAE, FAAN
         Chief Executive Officer, Infusion Nurses Society

Lisa Christopher-Stine, MD
         Co-Director, Johns Hopkins Myositis Center
         Assistant Professor of Medicine, Johns Hopkins University
         School of Medicine

Robert Dracker, MD, MHA
         Clinical Associate Professor, Departments of Pathology & Pediatrics
         SUNY Health Science Center at Syracuse
         Owner and Medical Director, Summerwood Pediatrics      
         Founder and Medical Director, Infusacare Medical Services, P.C.

Neil Herson
         President, ASD Healthcare

Todd Levine, MD
         Co-Director of Peripheral Neuropathy Clinic
         Banner Good Samaritan Medical Center
         Clinical Assistant Professor, University of Arizona

Flemming Nielsen
         President, Octapharma USA

Patrick Schmidt
         Chief Executive Officer, FFF Enterprises

Dominick Spatafora
         President, Neuropathy Action Foundation
         Diagnosis of multi-focal neuropathy treated successfully
         with monthly IVIG

Tina Tockarshewsky
         President and Chief Executive Officer, The Neuropathy Association

Michelle Vogel, Ex-Officio
         Executive Director, Alliance for Plasma Therapies
         Diagnosis of von Willebrand disease and autoimmune disorders